We are live on ! Find out more
KCM

KRS Capital Management Portfolio holdings

AUM $215M
1-Year Est. Return 69.3%
This Fund
S&P 500
This Quarter Est. Return
-5.88%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$72.5M
AUM Growth
+$2.3M
Cap. Flow
+$515K
Cap. Flow %
0.71%
Top 10 Hldgs %
42.25%
Holding
101
New
4
Increased
56
Reduced
16
Closed
6

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$346K
2
LLY icon
Eli Lilly
LLY
+$273K
3
WDAY icon
Workday
WDAY
+$223K
4
COST icon
Costco
COST
+$205K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$198K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$365K
2
UNP icon
Union Pacific
UNP
+$246K
3
COHR icon
Coherent
COHR
+$235K
4
FDX icon
FedEx
FDX
+$232K
5
ENB icon
Enbridge
ENB
+$214K

Sector Composition

Rank Sector Weight
1 Technology 43.31%
2 Healthcare 15.22%
3 Consumer Discretionary 9.06%
4 Financials 6.72%
5 Communication Services 5.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XYZ
26
Block Inc
XYZ
$50.4B
$706K 0.97%
12,849
+585
+5% +$41.4K
XOM icon
27
ExxonMobil
XOM
$638B
$680K 0.94%
7,794
+13
+0.2% +$1.19K
TMO icon
28
Thermo Fisher Scientific
TMO
$212B
$672K 0.93%
1,326
– –
NKE icon
29
Nike
NKE
$63.3B
$669K 0.92%
8,058
+204
+3% +$22K
CVS icon
30
CVS Health
CVS
$133B
$632K 0.87%
6,628
+431
+7% +$42.7K
CSCO icon
31
Cisco
CSCO
$457B
$615K 0.85%
15,393
+1,680
+12% +$74.5K
TSLA icon
32
Tesla
TSLA
$1.29T
$612K 0.84%
2,310
+60
+3% +$16.8K
JNJ icon
33
Johnson & Johnson
JNJ
$613B
$605K 0.83%
3,709
+7
+0.2% +$1.19K
LOW icon
34
Lowe's Companies
LOW
$119B
$594K 0.82%
3,166
-76
-2% -$14.8K
V icon
35
Visa
V
$683B
$575K 0.79%
3,241
+245
+8% +$49.9K
PAYX icon
36
Paychex
PAYX
$41.9B
$555K 0.77%
4,950
+77
+2% +$9.54K
DIS icon
37
Walt Disney
DIS
$170B
$553K 0.76%
5,871
+195
+3% +$20.9K
LRCX icon
38
Lam Research
LRCX
$369B
$548K 0.76%
14,970
– –
PG icon
39
Procter & Gamble
PG
$338B
$544K 0.75%
4,311
+152
+4% +$21.6K
SBUX icon
40
Starbucks
SBUX
$118B
$544K 0.75%
6,456
+278
+4% +$23.6K
HBAN icon
41
Huntington Bancshares
HBAN
$35.1B
$530K 0.73%
40,254
+1,348
+3% +$18K
NXPI icon
42
NXP Semiconductors
NXPI
$56.5B
$530K 0.73%
3,596
– –
ZS icon
43
Zscaler
ZS
$26.4B
$529K 0.73%
3,222
– –
ACN icon
44
Accenture
ACN
$101B
$526K 0.73%
2,045
+65
+3% +$18.8K
CRWD icon
45
CrowdStrike
CRWD
$215B
$524K 0.72%
12,720
– –
LULU icon
46
lululemon athletica
LULU
$14B
$497K 0.69%
1,778
+25
+1% +$7.75K
AMZN icon
47
Amazon
AMZN
$2.99T
$472K 0.65%
4,180
– –
AMGN icon
48
Amgen
AMGN
$210B
$468K 0.65%
2,077
+93
+5% +$22.5K
CYBR
49
DELISTED
CyberArk
CYBR
$457K 0.63%
3,050
– –
UPS icon
50
United Parcel Service
UPS
$90.8B
$457K 0.63%
2,830
+191
+7% +$36.2K
1
2
3 4 5

Similar funds

VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM
CMBA
C.M. Bidwell & Associates Honolulu, Hawaii $214M AUM 18.82% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return

KRS Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, KRS Capital Management held 101 positions worth $72.5M, up 3.3% from $70.2M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

KRS Capital Management's Q3 2022 filing shows 4 new, 56 increased, 16 reduced and 6 closed positions. Its largest new stake was Pfizer: 7,115 shares worth $311K. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $365K.

By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 48% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • KRS Capital Management's largest Q3 2022 buy was Pfizer: 7,115 shares worth $311K.
  • KRS Capital Management added most to Eli Lilly in Q3 2022, an estimated $273K increase.
  • KRS Capital Management's biggest Q3 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $365K.
  • KRS Capital Management fully exited Union Pacific in Q3 2022, selling an estimated $246K.
  • KRS Capital Management's ten largest holdings make up 42% of its $72.5M portfolio in Q3 2022.
  • KRS Capital Management opened 4 new positions and closed 6 in Q3 2022.
  • KRS Capital Management's portfolio value rose 3.3% quarter-over-quarter to $72.5M.

Based on KRS Capital Management's 13F filing for Q3 2022, filed 21 Oct 2022.